4
Changes in Ownership
BlossomHill Therapeutics, Inc. Filed Acc 0001231919-26-000852
Director bought 312,500 shares at $16.00 ($5,000,000)
- Director acquired 3,301,534 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chen Bihua Director | 2026-08-10 | Conversion | +1,599,993 | 1,599,993 | I: show line 1 in the form | ||
| Chen Bihua Director | 2026-08-10 | Conversion | +1,701,541 | 3,301,534 | I: show line 2 in the form | ||
| Chen Bihua Director | 2026-08-10 | Purchase | +312,500 | $16.00 | $5,000,000 | 3,614,034 | I: show line 3 in the form |
| Open-market purchases · 312,500 sh · avg $16.00 · $5,000,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Chen Bihua Director | 2026-08-06 | Grant or award · Director Stock Option (Right to Buy) | +23,904 | 23,904 | D: show line 4 in the form | |||||
| Chen Bihua Director | 2026-08-10 | Conversion · Series A Preferred Stock | −1,599,993 | 0 | I: show line 5 in the form | |||||
| Chen Bihua Director | 2026-08-10 | Conversion · Series B Preferred Stock | −1,701,541 | 0 | I: show line 6 in the form |
Loading xslF345X06/form4-08102026_100859.xml…